TC
AMPH icon

Truvestments Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Truvestments Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-96
Closed -$1.88K – 1153
2026
Q1 		$1.88K Sell
96
-58
-38% -$1.42K ﹤0.01% 1011
2025
Q4 		$4.12K Hold
154
– – ﹤0.01% 829
2025
Q3 		$4.1K Sell
154
-163
-51% -$4.21K ﹤0.01% 857
2025
Q2 		$7.28K Hold
317
– – ﹤0.01% 690
2025
Q1 		$9.19K Sell
317
-33
-9% -$1.05K ﹤0.01% 672
2024
Q4 		$13K Buy
350
+152
+77% +$6.95K ﹤0.01% 564
2024
Q3 		$9.61K Buy
+198
New +$8.69K ﹤0.01% 591

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Truvestments Capital's AMPH Position: Q2 2026 in Review

Truvestments Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 96 shares — an estimated $1.88K sold.

Truvestments Capital first reported a position in AMPH in Q3 2024 and held it in 7 quarters. The position peaked at $13K in Q4 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Truvestments Capital reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Truvestments Capital sold 96 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.88K.
  • Truvestments Capital first reported a position in Amphastar Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Truvestments Capital's Amphastar Pharmaceuticals position peaked at $13K in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.